Skip to main content
. 2013 Jan 27;28(7):1888–1898. doi: 10.1093/ndt/gfs593

FIGURE 1:

FIGURE 1:

The percent of patients receiving the wide ranges of weekly ESA doses in the daily FHN trial. Note those subjects receiving >50 000 units/week were not plotted.